Pathogenic/likely pathogenic variants in SMAD4 (encoding the transcription factor Smad4) have been described in less than 2% of the HHT population associated with juvenile polyposis/HHT overlap syndrome [8]. The gene discussed is SMAD4; the disease is hereditary hemorrhagic telangiectasia.